Financial statements Mezoderm

Balance sheet of Mezoderm

Company age:
Age:
11 y. 7 m. 27 d.
Share capital:
Share capital:
100 000 PLN

Balance sheet data of MEZODERM

Year
2018
2019
2020
2021
2022
Total assets 481 574,46 633 894,14 724 666,05 737 827,25 500 166,17
A. Fixed assets 18 535,08 22 873,60 4 583,28 0,00 15 444,49
B. Current assets 463 039,38 611 020,54 720 082,77 737 827,25 484 721,68
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 481 574,46 633 894,14 724 666,05 737 827,25 500 166,17
A. Equity 365 142,71 492 040,66 566 821,76 574 640,63 481 578,98
B. Liabilities and provisions for liabilities 116 431,75 141 853,48 157 844,29 163 186,62 18 587,19
I. Long-term liabilities 0,00 0,00 108 000,00 72 000,00 0,00
II. Short-term liabilities 116 431,75 136 178,03 49 844,29 88 153,29 18 587,19
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.